Excited that Henry Ford Health Henry Ford Hospital Cardiology Fellowship was the 6th hospital in the country to use BostonSci Cardiology Agent DCB earlier this week. Wonderful to have this technology for our complex patients!

Congratulations to Dr Arash Arshi & the team at OhioHealth Riverside Methodist on the 1st Coronary DCB case in Central Ohio & one of the first cases in the Country. Agent DCB represents a new paradigm in the management of ISR & has the ability to impact countless patient lives!

🪨Embracing Sisyphus: Finding Purpose Through Struggle🗻

Finding Purpose Through Struggle, Not Goals

Albert Camus’s interpretation of the myth of Sisyphus offers profound insights into our existence. Condemned to an eternal task of pushing a boulder up a hill, only to watch it

Used Agent-DCB for first time yesterday
CTO LCx-OM within two layers of stents
crossed antegrade and used Guide extension to deliver DCB which is recommended in torturous vessels and distal targets Mohammad Al-Qarqaz Henry Ford Hospital Cardiology Fellowship Henry Ford Health #CHIP #CTO #DCB

We completed the first human implant today for the new VITALYST Mechanical Circulatory Pump as part of an international Early Feasibility Study! Congrats to the Brigham and Women’s Hospital and Boston Scientific Research Teams that made this innovation possible. Robert W. Yeh MD Matthias Götberg

Live #coronary case with AGENT ISR drug-coated balloon from Stanford University Medical Center at #SCAI2024 . Stanford Department of Medicine

Live case SCAI Now #SCAI2024 presenting Drug eluting ballon for ISR
🔑🔑imaging systematically
🔑🔑prep
Before using drug eluting ballon
George Dangas, MD, MACC, MSCAI Sunil V. Rao Emmanouil Brilakis Nadia Sutton Morton J Kern Dr. Seto Poonam Velagapudi Allison Dupont, MD Jay Bagai Faisal Latif

Congratulations to Dr. Jennifer Tremmel and the Stanford Medicine team for completing the first live case using the AGENT™ Drug-Coated Balloon (DCB) in the US!

Visit us at SCAI Now to learn more about this new technology.

Great live cases at #SCAI2024 this am - textbook imaging and physiology case to guide “drug delivery system” for ISR SCAI Now @scaielm William Fearon and Jenn Tremmel

Watch Now! The 'First American AGENT: DCB for ISR' at opci.live featuring operators Dr. Richard Shlofmitz and @drallenj. BostonSci Cardiology #CardioTwitter Ziad Ali Evan Shlofmitz David J. Cohen, MD, MSc Dr. Jeffrey W. Moses

Attending #SCAI2024 ? We are excited to announce the first live case using AGENT Drug-Coated Balloon in the US will be happening at SCAI Now this Saturday, May 4th.

SCAI Now had begun with a great talk about the role of intravascular imaging #IVUS and #OCT by Evan Shlofmitz. Not all calcific lesions are created equal and the should be treated accordingly. Calcification depth is a relevant variable and OCT is superior than IVUS on that regard.

Happening now at #SCAI2024 —Imaging Guided Approach to Coronary #Calcium : Application of the SCAI Consensus Document. Review the document here in MyJSCAI 📰🔗 doi.org/10.1016/j.jsca…

Congrats to Dr. Richard Shlofmitz, Drs. Evan Shlofmitz, Ziad Ali, Allen Jeremias, Fernando Sosa, Director of Operations, and team at St. Francis Hospital & Heart Center®, the top enrolling AGENT IDE site, for successfully reaching this milestone.

We’re thrilled to be part of the first ever commercial DCB in the U.S. Head to opci.live Saturday at 10am EST to watch the recorded case. St. Francis Hospital & Heart Center® in partnership with BostonSci Cardiology Evan Shlofmitz Allen Jeremias Ziad Ali 112266 gary David J. Cohen, MD, MSc Dr. Jeffrey W. Moses Robert W. Yeh MD

A new era in IC in the USA! The 1st commercial DCB St. Francis Hospital & Heart Center® Catholic Health in partnership with BostonSci Cardiology #agent . #richierich Evan Shlofmitz Allen Jeremias OPCI 112266 gary Me David J. Cohen, MD, MSc Dr. Jeffrey W. Moses Fernando A Sosa Robert W. Yeh MD

#ACC24 IVUS versus angiography-guided PCI for ACS

SIGNIFICANT difference in target-vessel failure between groups

Question for the IC experts: When would you NOT use IVUS?

Second Prospective Randomized Control Trial Demonstrating the Benefit of Peripheral IVUS! 237 patients with fempop disease randomized to IVUS-guided DCB treatment vs angio-guided DCB treatment. 14% improvement in patency at 1 year, aligned with results from prior 150 person

With U.S. FDA approval of @BostonSci's AGENT™ Drug-Coated Balloon ( #DCB ), there's now a new tool in the cardiologist's armamentarium (well, new to the U.S., that is). So, let's take a look back 4 decades ago (pre-stent) at Andreas Gruentzig's view of the balloon. #AngioHistory

We are excited to announce AGENT™ Drug-Coated Balloon is now FDA approved! AGENT is the first and only coronary drug-coated balloon in the U.S. and introduces a new treatment option for patients with in-stent restenosis. bit.ly/3wuLYiM